Khosla, VCs plow US$100m into blood test startup using AI

Khosla, VCs plow US$100m into blood test startup using AI
(Image: Bloomberg)
Bloomberg
(Bloomberg) -- Blood-testing company Karius Inc. raised US$100 million (NZ$166.8m) in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals. The funding round was led by existing investor Khosla Ventures alongside 5AM Ventures and Gilde Healthcare. The company declined to give its valuation. Redwood City, California-based Karius’ blood tests look for pathogens by comparing fragments of microbial DNA with a database of 20,000 genomic reference...

More Technology

Want to buy SpaceX stock? You have to know someone
Markets

Want to buy SpaceX stock? You have to know someone

Shares in Elon Musk’s rocket and satellite company are a hot ticket for investors.

OpenAI dissolves high-profile safety team after Sutskever’s Exit
Technology

OpenAI dissolves high-profile safety team after Sutskever’s Exit

OpenAI is now integrating the group more deeply across its research efforts.

Dawn of the satellite age
Technology

Dawn of the satellite age

Getting satellites moving around in space is a tall order that Dawn is set to fill.

Daisy Lab gets green light to scale up GMO trials
News in Brief

Daisy Lab gets green light to scale up GMO trials

The start-up is still bound by strict rules to work in a contained facility.

Greg Hurrell 16 May 2024